1 year return (CAGR)
52.46%
Biogen Inc Exchange (NASDAQ, USD)
BIIB
227.53
+3.04 (+1.41%)
HealthcareDrug Manufacturers - General
Loading...
3 year return (CAGR)
-5.36%
5 year return (CAGR)
-6.11%
10 year return (CAGR)
-2.69%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
32.37B
Price/Sales
3.25
Ent value
44.32B
Price/Book
1.72
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
38.76
PEG
43.06
Forward P/E
13.25
EPS growth
-18.69%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 217.68 |
| Daily high | 219.41 |
| Daily low | 215.33 |
| Daily Volume | 837K |
| All-time high | 438.43 |
| 1y analyst estimate | 236.22 |
| Beta | 0.16 |
| EPS (TTM) | 5.62 |
| Dividend per share | 0.00 |
| Ex-div date | 2 Feb 2017 |
| Next earnings date | 6 May 2026 |
Downside potential
Loading...
Downside potential data
| BIIB | S&P500 | |
| Current price drop from All-time high | -48.10% | -1.29% |
| Highest price drop | -90.00% | -56.47% |
| Date of highest drop | 30 Dec 1994 | 9 Mar 2009 |
| Avg drop from high | -35.51% | -10.68% |
| Avg time to new high | 40 days | 12 days |
| Max time to new high | 2891 days | 1805 days |
News
